Evidence map›Paper›PMID 29713043›Full record

ArticleInternational journal of obesity (2005)2018

Epigenome-wide association study of adiposity and future risk of obesity-related diseases.

Gianluca Campanella, Marc J Gunter, Silvia Polidoro, Vittorio Krogh, Domenico Palli, Salvatore Panico, Carlotta Sacerdote, Rosario Tumino, Giovanni Fiorito, Simonetta Guarrera and 25 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 17 institutions in 9 countries.

Gianluca CampanellaDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Marc J GunterSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Silvia PolidoroItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Vittorio KroghFondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.
Domenico PalliIstituto per lo Studio e la Prevenzione Oncologica (ISPO Toscana), Florence, Italy.ORCID http://orcid.org/0000-0002-5558-2437
Salvatore PanicoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Carlotta SacerdoteItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, Azienda Ospedaliera "Civile-M.P. Arezzo", Ragusa, Italy.
Giovanni FioritoItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Simonetta GuarreraItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Licia IacovielloDepartment of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (IS), Italy.
Ingvar A BergdahlDepartment of Biobank Research, Umeå University, Umeå, Sweden.
Beatrice MelinDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Per LennerDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Theo M C M de KokDepartment of Toxicogenomics, Maastricht University, Maastricht, The Netherlands.
Panagiotis GeorgiadisInstitute of Biology, Medicinal Chemistry, and Biotechnology, National Hellenic Research Foundation, Athens, Greece.
Jos C S KleinjansDepartment of Toxicogenomics, Maastricht University, Maastricht, The Netherlands.
Soterios A KyrtopoulosInstitute of Biology, Medicinal Chemistry, and Biotechnology, National Hellenic Research Foundation, Athens, Greece.ORCID http://orcid.org/0000-0002-6821-6532
H Bas Bueno-de-MesquitaDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Karen A LillycropCentre for Biological Sciences, University of Southampton, Southampton, UK.
Anne M MayJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
N Charlotte Onland-MoretJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
Robert MurrayCentre for Biological Sciences, University of Southampton, Southampton, UK.
Elio RiboliDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Monique VerschurenCentre for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Eiliv LundDepartment of Community Medicine, University of Tromsø (UiT)-The Artic University of Norway, Tromsø, Norway.
Nicolle ModeDepartment of Community Medicine, University of Tromsø (UiT)-The Artic University of Norway, Tromsø, Norway.
Torkjel M SandangerDepartment of Community Medicine, University of Tromsø (UiT)-The Artic University of Norway, Tromsø, Norway.
Valentina FianoDepartment of Medical Sciences, Unit of Cancer Epidemiology-CERMS, University of Turin, Turin, Italy.
Morena TrevisanDepartment of Medical Sciences, Unit of Cancer Epidemiology-CERMS, University of Turin, Turin, Italy.
Giuseppe MatulloItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Philippe FroguelCNRS UMR8199, Pasteur Institute of Lille, Lille University, Lille, France.ORCID http://orcid.org/0000-0003-2972-0784
Paul ElliottDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-7511-5684
Paolo VineisDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Marc Chadeau-HyamDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK. m.chadeau@imperial.ac.uk.ORCID http://orcid.org/0000-0001-8341-5436
Italian institute for Genomic Medicine · ITImperial College London · GBUiT The Arctic University of Norway · NOUmeå University · SEUniversity Medical Center Utrecht · NLDepartment of Medical Sciences · BYMaastricht University · NLNational Hellenic Research Foundation · GRUniversity of Southampton · GBAzienda Usl 8 Arezzo · ITCentre international de recherche sur le cancer · FRCentre National de la Recherche Scientifique · FRFondazione IRCCS Istituto Nazionale dei Tumori · ITIstituto Neurologico Mediterraneo · ITIstituto per lo Studio e la Prevenzione Oncologica · ITNational Institute for Public Health and the Environment · NLUniversity of Naples Federico II · IT

Funding

British Heart Foundation RG/15/17/31749Medical Research Council MR/L01341X/1World Health Organization 001
6 · The paper itself

Abstract

backgroundObesity is an established risk factor for several common chronic diseases such as breast and colorectal cancer, metabolic and cardiovascular diseases; however, the biological basis for these relationships is not fully understood. To explore the association of obesity with these conditions, we investigated peripheral blood leucocyte (PBL) DNA methylation markers for adiposity and their contribution to risk of incident breast and colorectal cancer and myocardial infarction.

methodsDNA methylation profiles (Illumina Infinium

resultsWe identified 40 CpG loci with methylation levels associated with at least one adiposity measure. Of these, one CpG locus (cg06500161) in ABCG1 was associated with all four adiposity measures (P = 9.07×10

conclusionOur results suggest that epigenetic changes, in particular altered DNA methylation patterns, may be an intermediate biomarker at the intersection of obesity and obesity-related diseases, and could offer clues as to underlying biological mechanisms.

Indexed as

Myocardial InfarctionNeoplasmsObesityAdiposityDNA MethylationEpigenomicsGenetic MarkersGenome-Wide Association StudyHumansLeukocytes, MononuclearGenetic Markers

Identifiers

PMID29713043
OpenAlexW2801387160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.